[Expression of human granulysin in murine macrophages and its effects on cell damage and apoptosis]

Zheng-jun Yi1, Dao-yin Zhu, Jun-ming Li

  • 1Department of Microbiology and Immunology, Chongqing University of Medical Sciences, Chongqing 400016, China. yizhengjun@sohu.com

Abstract

Insights

Human granulysin (GLS) was successfully expressed in murine macrophages using the pBudCE4.1/GLS vector. The study found no significant cell damage or apoptosis in host cells following GLS expression.

Area of Science:

  • Molecular biology
  • Immunology
  • Cell biology

Context:

  • Granulysin (GLS) is a key cytotoxic protein found in activated cytotoxic T lymphocytes (CTLs).
  • Understanding GLS expression and its effects in different cellular contexts is crucial for immunotherapy research.
  • Murine macrophages are key immune cells involved in host defense and inflammation.

Purpose:

  • To construct an eukaryotic expression vector, pBudCE4.1/GLS, for human granulysin (GLS).
  • To investigate the expression of human GLS in murine macrophages.
  • To evaluate the impact of GLS expression on macrophage cell damage and apoptosis.

Summary:

  • The pBudCE4.1/GLS vector was successfully constructed and transfected into murine macrophages.
  • Human GLS was confirmed to be expressed in the target cells 48 hours post-transfection via RT-PCR and immunocytochemistry.
  • No significant alterations in cell damage (LDH levels) or apoptosis (nuclear DNA staining) were observed.

Impact:

  • Demonstrates the feasibility of expressing human granulysin in murine macrophages.
  • Provides foundational data on the non-cytotoxic effects of human GLS in macrophages.
  • Suggests potential for further investigation into GLS function and therapeutic applications in immune modulation.

Related Concept Videos